Back to Newsroom

Cempra to Present Data on Solithromycin at ECCMID Highlighting Potential New Indications, Safety and Activity Spectrum

CHAPEL HILL, N.C., May 9, 2014 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP) today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain, that continue to enhance the profile of solithromycin in regards to potential new indications, safety and spectrum of activity particularly against contemporary strains. Presentations will occur on Saturday, May 10 to Tuesday, May 13.

Click here to read more